A discussion of gland mechanisms, how they can go awry and
what you can do to nurse them back to health.
Research has led to better, more diverse ways to reach a diagnosis, let alone more knowledge about DED itself.
Antioxidants’ effects on harmful reactive oxygen species may be helpful in the fight against dry eye.
Novaliq Begins Phase 2 Clinical Trial of CyclASol for the Treatment of Moderate to Severe Dry Eye Disease
A look at neuropathic pain and its relationship to dry-eye diagnosis and therapeutic strategies.
How increasing the absorption, bioavailability and/or retention of a drug can result in better efficacy without greater side effects.
New compounds, especially those derived from hyaluronic acid, may change the game of dry-eye treatment.
Ophthalmic Product Development Insights
Allergan Enters Into Licensing Agreement with Mimetogen Pharmaceuticals to Develop and Commercialize Tavilermide (MIM-D3) Topical Dry Eye Treatment
Novel compounds of all sorts, from anti-inflammatories to receptor inhibitors, are on the way.